S. Bezstarosti

Cardiovascular Effects of Autologous Bone Marrow–Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study

Jeroen J. Bax, K. E. Groeneweg, J. D. de Fijter, 2021, Journal of the American Heart Association.

A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry

J. D. de Fijter, F. Claas, M. Reinders, 2022, Frontiers in Immunology.

Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes.

J. D. de Fijter, F. Claas, M. Reinders, 2021, Human immunology.

HLA-DQ-Specific Recombinant Human Monoclonal Antibodies Allow for In-Depth Analysis of HLA-DQ Epitopes

J. D. de Fijter, D. Roelen, F. Claas, 2022, Frontiers in Immunology.

Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantation

M. Schilham, J. D. de Fijter, S. Heidt, 2022, British journal of clinical pharmacology.

HLA‐DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor‐specific antibody formation after mesenchymal stromal cell therapy

K. E. Groeneweg, J. D. de Fijter, D. Roelen, 2023, HLA.

Two Human Monoclonal HLA-Reactive Antibodies Cross-React with Mamu-B*008, a Rhesus Macaque MHC Allotype Associated with Control of Simian Immunodeficiency Virus Replication

R. Bontrop, F. Claas, N. D. de Groot, 2021, The Journal of Immunology.

HLA antibody affinity determination: From HLA‐specific monoclonal antibodies to donor HLA specific antibodies (DSA) in patient serum

F. Claas, S. Heidt, D. Meinel, 2023, HLA.